ViroCell Biologics is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials.
Location: United Kingdom, England, London
Employees: 11-50
Founded date: 2020
Investors 1
| Date | Name | Website |
| 23.02.2022 | Disruptive... | disruptive... |
Mentions in press and media 1
| Date | Title | Description |
| 15.08.2024 | ViroCell Biologics Closes Convertible Note Financing | ViroCell Biologics, a London, UK- and NYC-based cell and gene therapy contract development and manufacturing organization, raised an undisclosed amount in convertible note funding. The round was led by First Light Asset Management LLC, join... |